Caron Winslow

Caron Winslow has a diverse work experience in various industries. Caron is currently working at SomaLogic as the Director of Strategic Alliances and Corporate Development. In this role, they are responsible for fostering partnerships and managing corporate development initiatives. Prior to this, they served as the Director of Global Strategic Accounts at SomaLogic, where they developed and managed global accounts. Before joining SomaLogic, Caron worked at Promega Corporation as a Scientific Client Consultant, focusing on strategic accounts. Caron also served as a Field Applications Specialist at Promega Corporation. Caron has held the position of Key Account Manager at Monster Worldwide, Inc, where they managed key accounts. Caron gained experience in the pharmaceutical industry as a Vaccine Sales Executive at Merck & Co; Inc. Caron's earlier career includes roles as a Research Associate and Lab Manager at Brandeis University and as an Independent Researcher at the University of New Hampshire.

Caron Winslow's education history begins with a Bachelor of Science in Biochemistry from the University of New Hampshire, which was completed in 2003. In 2005-2006, Caron pursued graduate coursework in Molecular Biology and Biochemistry at Brandeis University. From 2012 to 2014, Caron attended Harvard University for additional graduate coursework, focusing on Biotechnology. Most recently, in 2019, Caron obtained a Certificate in Artificial Intelligence: Implications for Business Strategy from the MIT Sloan School of Management.